- Home
- BIOX vs PRQR Comparison
BIOX vs PRQR Comparison
Compare BIOX & PRQR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BIOX
- PRQR
- Stock Information
- Founded
- BIOX 2001
- PRQR 2012
- Country
- BIOX Argentina
- PRQR Netherlands
- Employees
- BIOX N/A
- PRQR N/A
- Industry
- BIOX Agricultural Chemicals
- PRQR Biotechnology: Pharmaceutical Preparations
- Sector
- BIOX Industrials
- PRQR Health Care
- Exchange
- BIOX Nasdaq
- PRQR Nasdaq
- Market Cap
- BIOX 275.1M
- PRQR 309.5M
- IPO Year
- BIOX N/A
- PRQR 2014
- Fundamental
- Price
- BIOX $4.30
- PRQR $1.43
- Analyst Decision
- BIOX Strong Buy
- PRQR Strong Buy
- Analyst Count
- BIOX 4
- PRQR 5
- Target Price
- BIOX $8.63
- PRQR $9.80
- AVG Volume (30 Days)
- BIOX 133.1K
- PRQR 583.9K
- Earning Date
- BIOX 05-12-2025
- PRQR 05-08-2025
- Dividend Yield
- BIOX N/A
- PRQR N/A
- EPS Growth
- BIOX N/A
- PRQR N/A
- EPS
- BIOX 0.02
- PRQR N/A
- Revenue
- BIOX $407,732,105.00
- PRQR $20,235,014.00
- Revenue This Year
- BIOX N/A
- PRQR $6.44
- Revenue Next Year
- BIOX $7.55
- PRQR N/A
- P/E Ratio
- BIOX $184.22
- PRQR N/A
- Revenue Growth
- BIOX N/A
- PRQR 196.41
- 52 Week Low
- BIOX $3.51
- PRQR $1.07
- 52 Week High
- BIOX $13.18
- PRQR $4.62
- Technical
- Relative Strength Index (RSI)
- BIOX 48.47
- PRQR 50.71
- Support Level
- BIOX $4.04
- PRQR $1.10
- Resistance Level
- BIOX $4.50
- PRQR $1.26
- Average True Range (ATR)
- BIOX 0.37
- PRQR 0.13
- MACD
- BIOX 0.04
- PRQR 0.07
- Stochastic Oscillator
- BIOX 65.94
- PRQR 73.47
About BIOX Bioceres Crop Solutions Corp.
Bioceres Crop Solutions Corp is a fully integrated provider of crop productivity solutions, including seeds, seed traits, seed treatments, biologicals, high-value adjuvants, and fertilizers. The company has developed a multi-discipline and multi-product platform capable of providing solutions throughout the entire crop cycle, from pre-planting to transportation and storage. Some of the products offered by the company include fertilizers, inoculants, adjuvants, crop protection solutions, and seeds among others. Its operating segments are crop protection, which derives key revenue, seed and integrated products, and crop nutrition. Geographically, the majority of the company's revenue is generated from Argentina and the rest from Brazil, North America, Latin America, and other regions.
About PRQR ProQR Therapeutics N.V.
ProQR Therapeutics NV is a biopharmaceuticals company. It discovers and develops RNA therapeutics for patients with severe genetic rare diseases such as cystic fibrosis, Leber's congenital amaurosis type 10 and dyastrophic epidermolysis bullosa.